Search results (12)
« Back to NewsThe latest news, stories and exciting findings from across the Oxford cancer research community
University of Oxford Lung cancer trial reaches 400 participants
8 April 2024
The SCOOT study seeks current and former smokers across England to provide blood samples for ongoing research aiming to improve lung cancer diagnosis.
New tool uses health records to predict risk of developing lung cancer within the next 10 years
6 April 2023
A team of researchers from the University of Oxford and the University of Nottingham have developed ‘CanPredict’, a new tool able to identify those most at risk of developing lung cancer over the next 10 years, and put them forward for screening tests earlier, saving time, money and lives.
Oxford spinout Optellum secures $14m funding to advance pioneering AI-powered lung cancer diagnosis technology
6 October 2022
Optellum, a University of Oxford spinout that provides a breakthrough AI platform to diagnose and treat early-stage lung cancer, has raised $14 million in a Series A funding round.
Oxford spin-out Optellum attains CE marking for its early lung cancer diagnosis AI technology
5 April 2022
Optellum Virtual Nodule Clinic, including its proprietary artificial intelligence lung cancer prediction solution, has achieved CE certification under the European Union’s Medical Device Regulation.
First patient dosed with lung cancer immunotherapy vaccine
18 January 2022
The first patient has been dosed in the MAGE trial, which is testing a novel immunotherapeutic known as VTP-600, in patients with the most common type of lung cancer.
New healthcare partnership for Oxfordshire cancer research spin-out
29 November 2021
Oxford University spin-out Optellum have announced their collaboration with GE Healthcare to advance lung cancer diagnosis using artificial intelligence.
Oxford Cancer Analytics awarded £1.27M to revolutonise lung cancer management
10 September 2021
OXcan, an Oxford University spin out, has raised money to apply their machine learning approach to lung cancer early detection
Oxford spin out partners with J&J to transform lung cancer treatment
18 August 2021
Optellum, a lung health start-up in Oxford, aims to redefine early interception of lung cancer using artificial intelligence (AI) decision support software.
AI software to help clinicians diagnose lung cancer earlier and reduce patient waiting lists
26 July 2021
A new artificial intelligence software that will help doctors to make quicker and more accurate decisions when diagnosing potentially cancerous lung lesions, has received major government funding.
Oxford spin out influencing patient care world wide
27 March 2021
Oxford cancer research spin our Optellum has received FDA clearance for the world’s first AI-powered clinical decision support for early lung cancer diagnosis
QResearch researchers collaborate on two major cancer projects
8 July 2020
Researchers in the Primary Care Epidemiology Group are joining two landmark projects to combine healthcare data and artificial intelligence to improve cancer diagnosis
Oxford to lead new programme of AI research to improve lung cancer screening
3 July 2020
Science Minister Amanda Solloway today announced Oxford will lead a new national programme of AI research to improve lung cancer screening